Identifying the genetic mutations that increase a patient’s disease risk allows them to take action to reduce their chances of developing disease. Research recently published in Genome Medicine investigated the confidence we have in DNA sequencing results; co-author Rachel Goldfeder explains more in this post.
In the last month, the Breast Cancer Now Tissue Bank has hit the milestone of consenting and collecting samples from over 10,000 breast cancer patients. To find out more we asked Professor Wayne Phillips, chair of the Tissue Bank Advisory Council, about the Tissue Bank and how it’s supporting the breast cancer research community.
The National Kidney Foundation is calling all individuals to give their kidneys a second thought this March in light of it being National Kidney Month. Critical Care Editorial Board Members and authors Michael Joannidis, Lui Forni and Marlies Ostermann talk here about acute kidney injury, and why this is important to understand.
Cancer fear and fatalism can cost people their lives if it causes them to avoid cancer screening or seeing their doctor with symptoms. A new study from the Health Behaviour Research Centre, published today in the British Journal of Cancer, shows that cancer fear and fatalism may be more prevalent among ethnic minority groups, which could help explain their lower engagement with early detection of cancer.
Breast Cancer Research has today published research investigating the growth of breast tissue, and whether this can be grown successfully in the lab. In this guest blog, Amber Wood and Charles Streuli explain more.
The Journal of NeuroEngineering and Rehabilitation has published research looking at the use of virtual reality to help patients with multiple sclerosis maintain their balance, a common issue for those with the disease. Co-author Alon Kalron explains more.
Reported discrepancies between the information provided when the trial is registered and the data reported in publications is becoming a hot topic – especially with regards to outcome switching in randomised controlled trials. Updating the clinical trial record could be that missing link that differentiates between selective reporting and transparency of research.